暗战 2021
commented on
$Faraday Future Intelligent Electric Inc. (FFIE.US)$ Shorting this stock will make money at any time!
Translated
4
暗战 2021
commented on
$Faraday Future Intelligent Electric Inc. (FFIE.US)$ they took all our money and paid their leadership team. stayed afloat for a few more months. this will be delisted and they cannot reverse split again.
1
7
暗战 2021
commented on
$Faraday Future Intelligent Electric Inc. (FFIE.US)$ Can stocks continue to merge together? Has this rubbish stock merged tens of thousands of shares and still has a market cap of over 40 million?
Translated
2
暗战 2021
commented on
1
2
暗战 2021
commented on
$GeoVax Labs (GOVX.US)$ Why is it falling??
1
3
暗战 2021
commented on
$SciSparc (SPRC.US)$ Haha, is this another 21 million shares issued?
5
暗战 2021
commented on
$Transcode Therapeutics (RNAZ.US)$
The company issued another 10 million common stocks! (The total share capital is clearly stated. Why can they issue more shares out of thin air?), with a face value of $0.0001 per share (common stock), now selling to investors at $0.30 per share of common stock. It is expected that the company will receive a total revenue of 3 million US dollars related to this issuance, provided by the company after deducting placement agency fees and other payable issuance expenses. This offering is expected to end on July 24, 2024.
The company issued another 10 million common stocks! (The total share capital is clearly stated. Why can they issue more shares out of thin air?), with a face value of $0.0001 per share (common stock), now selling to investors at $0.30 per share of common stock. It is expected that the company will receive a total revenue of 3 million US dollars related to this issuance, provided by the company after deducting placement agency fees and other payable issuance expenses. This offering is expected to end on July 24, 2024.
Translated
1
9
暗战 2021
commented on
$Transcode Therapeutics (RNAZ.US)$
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
TransCode Therapeutics (Nasdaq: RNAZ), a clinical-stage RNA oncology company, has announced a proposed public offering of common stock and pre-funded warrants. The offering, managed by ThinkEquity as the sole placement agent, aims to raise funds for product development activities, including clinical trials for TTX-MC138, their lead therapeutic candidate. The company plans to use ...
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
TransCode Therapeutics (Nasdaq: RNAZ), a clinical-stage RNA oncology company, has announced a proposed public offering of common stock and pre-funded warrants. The offering, managed by ThinkEquity as the sole placement agent, aims to raise funds for product development activities, including clinical trials for TTX-MC138, their lead therapeutic candidate. The company plans to use ...
3
2
暗战 2021
reacted to
Translated
2
暗战 2021 : How can individual investors short sell?